Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Enterprise Value (2019 - 2025)

Historic Enterprise Value for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$278.9 million.

  • Legend Biotech's Enterprise Value rose 3927.56% to -$278.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$278.9 million, marking a year-over-year increase of 3927.56%. This contributed to the annual value of -$1.3 billion for FY2024, which is 4.64% up from last year.
  • Latest data reveals that Legend Biotech reported Enterprise Value of -$278.9 million as of Q3 2025, which was up 3927.56% from -$266.7 million recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Enterprise Value peaked at -$243.5 million during Q2 2024, and registered a low of -$1.4 billion during Q2 2023.
  • Moreover, its 5-year median value for Enterprise Value was -$459.3 million (2024), whereas its average is -$650.0 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 44662.56% in 2021, then surged by 8284.29% in 2024.
  • Legend Biotech's Enterprise Value (Quarter) stood at -$690.4 million in 2021, then crashed by 40.74% to -$971.6 million in 2022, then tumbled by 31.57% to -$1.3 billion in 2023, then skyrocketed by 77.56% to -$286.8 million in 2024, then increased by 2.76% to -$278.9 million in 2025.
  • Its Enterprise Value stands at -$278.9 million for Q3 2025, versus -$266.7 million for Q2 2025 and -$441.8 million for Q1 2025.